Evidence map›Paper›PMID 19922565›Full record

ReviewAddiction (Abingdon, England)2009

Anabolic-androgenic steroid dependence: an emerging disorder.

Gen Kanayama, Kirk J Brower, Ruth I Wood, James I Hudson, Harrison G Pope

Open access · bronzeAbstract readCase ReportsReview
In one paragraph

Review in Addiction (Abingdon, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 4 syntheses or guidelines pooled it, 290 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Article
  7. Article
  8. Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Gen KanayamaBiological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, and Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Kirk J Brower
Ruth I Wood
James I Hudson
Harrison G Pope
Harvard University · USMcLean Hospital · USUniversity of Michigan–Ann Arbor · USUniversity of Southern California · US

Funding

Risk Factors for Anabolic-Androgenic Steroid AbuseR01DA016744 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI POPE, HARRISON G · 2005 to 2009
$1.7M
NEUROBIOLOGY OF ANDROGEN REWARDR01DA012843 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WOOD, RUTH I. · 2001 to 2004
$813k
NIDA NIH HHS R01 DA012843NIDA NIH HHS R01 DA016744PHS HHS NIDA/DA 016744PHS HHS NIDA/DA 12843
6 · The paper itself

Abstract

aimsAnabolic-androgenic steroids (AAS) are widely used illicitly to gain muscle and lose body fat. Here we review the accumulating human and animal evidence showing that AAS may cause a distinct dependence syndrome, often associated with adverse psychiatric and medical effects.

methodWe present an illustrative case of AAS dependence, followed by a summary of the human and animal literature on this topic, based on publications known to us or obtained by searching the PubMed database.

resultsAbout 30% of AAS users appear to develop a dependence syndrome, characterized by chronic AAS use despite adverse effects on physical, psychosocial or occupational functioning. AAS dependence shares many features with classical drug dependence. For example, hamsters will self-administer AAS, even to the point of death, and both humans and animals exhibit a well-documented AAS withdrawal syndrome, mediated by neuroendocrine and cortical neurotransmitter systems. AAS dependence may particularly involve opioidergic mechanisms. However, AAS differ from classical drugs in that they produce little immediate reward of acute intoxication, but instead a delayed effect of muscle gains. Thus standard diagnostic criteria for substance dependence, usually crafted for acutely intoxicating drugs, must be adapted slightly for cumulatively acting drugs such as AAS.

conclusionsAAS dependence is a valid diagnostic entity, and probably a growing public health problem. AAS dependence may share brain mechanisms with other forms of substance dependence, especially opioid dependence. Future studies are needed to characterize AAS dependence more clearly, identify risk factors for this syndrome and develop treatment strategies.

Indexed as

Doping in SportsAdultAnabolic AgentsAnimalsCocaine-Related DisordersCricetinaeHumansMaleMental DisordersMuscle, SkeletalOpioid-Related DisordersPrevalenceAnabolic Agents

Identifiers

PMID19922565
PMCPMC2780436
OpenAlexW1987094115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.